Vaccine distribution is still unknown, stick with barbell approach: Nancy Tengler

Pfizer vaccine news propels stocks to new highs. CNBC's Kelly Evans discusses the market action and the impact of an effective coronavirus vaccine with Steve Auth of Federated Hermes, Nancy Tengler of Laffer Tengler and Peter Boockvar of Bleakley Advisory Group. I think the fundamentals are really good, says Tengler. And the news today just sort of opened the floodgates to allow investors to see that, she adds.